--- title: "Pre-market hot trades in US stocks: U-BX Tech pre-market down 10.24%; FuelCell Energy pre-market up 7.88%" type: "News" locale: "en" url: "https://longbridge.com/en/news/291135177.md" description: "U-BX Tech pre-market down 10.24%; FuelCell Energy pre-market up 7.88%; Nature's Way pre-market up 176.94%; Decoy Therapeutics pre-market up 130.52%; Inlif pre-market up 51.82%" datetime: "2026-06-29T11:12:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291135177.md) - [en](https://longbridge.com/en/news/291135177.md) - [zh-HK](https://longbridge.com/zh-HK/news/291135177.md) --- # Pre-market hot trades in US stocks: U-BX Tech pre-market down 10.24%; FuelCell Energy pre-market up 7.88% **Pre-market Hot Trades in US Stocks** U-BX Tech, down 10.24% in pre-market trading, has no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. FuelCell Energy is up 7.88% in pre-market trading. Based on recent key news: 1. On June 27, Jefferies upgraded FuelCell Energy's rating from Hold to Buy, raising the target price from $16 to $24. This move is due to the company's power contract order for a data center in the U.S. with Fit Energy, shifting the investment thesis from speculative to executable, resulting in a 20.8% increase in stock price. Source: Benzinga 2. On June 26, the MACD indicator showed increased buying pressure, with the stock price rising to $24.66, up 25.50% from the previous day. The MACD is above the signal line, indicating that buyers are quickly absorbing the pullback and maintaining trend control. Source: Benzinga 3. On June 27, the average analyst target price was $18.83, suggesting a 22.85% upside potential for the stock price. After the company's data center energy deal, analysts may update their coverage on FuelCell Energy. Source: Benzinga Clean energy ETFs are performing strongly, with an optimistic industry outlook. **Top Gainers in Pre-market US Stocks** Nature's Sunshine Products is up 176.94% in pre-market trading. Based on recent key news: 1. On June 26, Nature's Sunshine Products announced the acquisition of Best Praise International Limited for $10.75 million, paid by issuing 4,376,552 shares of common stock. This move aims to expand its pharmaceutical patent portfolio, significantly boosting the stock price. Source: Reuters 2. On June 27, Universe Pharmaceuticals issued a press release detailing the strategic significance of acquiring Best Praise, emphasizing the potential of its five patents in China, further enhancing market confidence. Source: GlobeNewswire 3. On June 27, the market reacted positively to Nature's Sunshine Products' acquisition plan, with the stock price significantly rising in pre-market trading, reflecting investors' optimistic expectations for its future development. Source: WSJ The pharmaceutical industry has seen frequent acquisition activities recently, increasing market volatility. Decoy Therapeutics is up 130.52% in pre-market trading. Based on recent key news: 1. On June 27, Decoy Therapeutics announced a private placement financing of up to $21 million. This financing plan enhances the company's financial strength, supporting its business expansion and significantly boosting the stock price. Source: Reuters 2. On June 26, Decoy Therapeutics launched an innovative product, Designable Multi-Antivirals (D-MAVs™), aimed at targeting common mechanisms across multiple virus families The release of this product has raised market expectations for the company's future growth, further driving up the stock price. Source: Reuters On June 29, Decoy Therapeutics signed a lock-up agreement with Curvature Securities to support orderly trading after financing. This move helps stabilize market sentiment and maintain the upward trend of the stock price. Source: SEC announcement on the biotechnology industry's innovative products driving stock price increases. Inlif pre-market rose 51.82%. Based on recent key news: On June 26, TipRanks' AI analyst Spark rated INLF stock as neutral, with a target price of $0.05. The analyst pointed out that the financial performance in 2025 is expected to deteriorate sharply, including loss results and negative cash flow, while the technical aspect is very weak, with momentum severely oversold and the stock price far below major moving averages, leading to stock price volatility. Recent market fluctuations have intensified, and risks need to be monitored ### Related Stocks - [UBXG.US](https://longbridge.com/en/quote/UBXG.US.md) - [FCEL.US](https://longbridge.com/en/quote/FCEL.US.md) - [MF.US](https://longbridge.com/en/quote/MF.US.md) - [UPC.US](https://longbridge.com/en/quote/UPC.US.md) - [DCOY.US](https://longbridge.com/en/quote/DCOY.US.md) - [INLF.US](https://longbridge.com/en/quote/INLF.US.md) ## Related News & Research - [A $225 Million Reason to Sell FuelCell Energy Stock Now](https://longbridge.com/en/news/292382219.md) - [Here Is How to Play FuelCell Energy Stock After the Jefferies Upgrade](https://longbridge.com/en/news/291176046.md) - [FCEL Stock Skyrockets as FuelCell Secures $49 Million Financing Deal](https://longbridge.com/en/news/291302051.md) - [Why Did FuelCell Energy Stock (FCEL) Sink Today — July 10, 2026?](https://longbridge.com/en/news/292361163.md) - [FuelCell Energy files prospectus supplement; Latham & Watkins legal opinion attached](https://longbridge.com/en/news/293384949.md)